By using this approach of computational or in-silico drug design we determined the anticancer potential of Moringa oleifera in ER + breast cancer targeting CDK-2 enzyme & evaluated our results using Maestro v13.2, Schrödinger. The gene discussed is CDK2; the disease is breast carcinoma.